InvestorsHub Logo
Followers 34
Posts 2681
Boards Moderated 0
Alias Born 10/28/2013

Re: bigstocksnbonds post# 8006

Thursday, 07/23/2015 9:04:48 AM

Thursday, July 23, 2015 9:04:48 AM

Post# of 482054
It is possible they already have an arrangement with a big pharma, but that is an unknown. BP has allowed other companies to do trials with their blockade inhibitors as adjunts, without having to partner for the trials. So maybe it is not that big a deal. Just don't know. I would ask around. Also, will they have to redesign their Ph2 if they add the blockade inhibitors? They have approval for their Ph2 trial design... does that include the blockade inhibitors? Probably not. So they would probably have to start over negotiating with the FDA.

The current Ph1 data just says they generated T-Cells. The data says nothing about actually effecting the cancer. So while their products could be fantastic, there really isn't much evidence yet.

Unlike Anavex 2-73 that has patients and caregivers asking, "Can we have more, please sir?"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News